Who owns Autolus Therapeutics plc?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of AUTL from SEC Form 13F filings across 60 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 60 institutions disclosed 41.5M shares of Autolus Therapeutics plc worth $66.2M — about 15.6% of shares outstanding; the largest disclosed holder is Blackstone Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
60
13F holders
$66.2M
value, 2026 filers
15.6%
of shares outstanding (41.5M sh)
7
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of AUTL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Blackstone Inc. | 20.5M | $32.8M | 0.1% | 7.7% | 0.0% |
| 2 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 3.4M | $5.4M | 0.0% | 1.3% | 0.0% |
| 3 | Laurion Capital Management LP | 3.3M | $5.3M | 0.1% | 1.2% | 0.0% |
| 4 | BANK OF AMERICA CORP /DE/ | 1.6M | $2.6M | 0.0% | 0.6% | -13.0% |
| 5 | BlackRock, Inc. | 1.6M | $2.6M | 0.0% | 0.6% | +8.3% |
| 6 | UBS Group AG | 1.5M | $2.4M | 0.0% | 0.6% | +16.2% |
| 7 | MORGAN STANLEY | 1.3M | $2.0M | 0.0% | 0.5% | +33.9% |
| 8 | MILLENNIUM MANAGEMENT LLC | 1.2M | $2.0M | 0.0% | 0.5% | +498.3% |
| 9 | Cetera Investment Advisers | 1.2M | $1.9M | 0.0% | 0.4% | +2.5% |
| 10 | Balyasny Asset Management L.P. | 972,748 | $1.6M | 0.0% | 0.4% | +0.1% |
| 11 | JPMORGAN CHASE & CO | 913,239 | $1.5M | 0.0% | 0.3% | -2.4% |
| 12 | Alphabet Inc. | 698,262 | $1.1M | 0.0% | 0.3% | 0.0% |
| 13 | CITADEL ADVISORS LLC | 695,890 | $1.1M | 0.0% | 0.3% | +51.5% |
| 14 | Privium Fund Management B.V. | 363,430 | $581,488 | 0.1% | 0.1% | 0.0% |
| 15 | EDENTREE ASSET MANAGEMENT Ltd | 300,000 | $477,000 | 0.1% | 0.1% | 0.0% |
| 16 | JANE STREET GROUP, LLC | 299,862 | $479,779 | 0.0% | 0.1% | +22.0% |
| 17 | WELLS FARGO & COMPANY/MN | 212,592 | $340,147 | 0.0% | 0.1% | +2.3% |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 177,232 | $283,572 | 0.0% | 0.1% | -55.6% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 123,934 | $198,294 | 0.0% | 0% | +12.1% |
| 20 | Clearstead Advisors, LLC | 121,107 | $193,772 | 0.0% | 0% | 0.0% |
| 21 | GOLDMAN SACHS GROUP INC | 113,556 | $181,690 | 0.0% | 0% | -2.5% |
| 22 | Leonteq Securities AG | 100,000 | $160,000 | 0.0% | 0% | 0.0% |
| 23 | MARSHALL WACE, LLP | 94,654 | $151,445 | 0.0% | 0% | +254.7% |
| 24 | HRT FINANCIAL LPNEW | 89,363 | $142 | 0.0% | 0% | new |
| 25 | Point72 Asset Management, L.P. | 71,227 | $113,963 | 0.0% | 0% | -83.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.